A multinational, interdisciplinary forum for exchanging the most up-to-date knowledge in pharmaceutical sciences, technology, and business — with keynote plenaries, six parallel tracks, roundtables, lunch seminars, and the year’s best networking.
Theme: Accelerating Drug Discovery and Development with AI and New Modalities. More than 1,000 scientists and industry leaders gathered at the Sheraton Valley Forge Hotel, King of Prussia, PA, for the 24th Annual Conference (in partnership with DIA). Click any session below to expand its details.
Presenters: Andrew Tsourkas, Ph.D. (AlphaThera); Lake Paul, Ph.D. (BioAnalysis); Lixia Yao, Ph.D. (Polygon Health Analytics); Frank Li, Ph.D. (Sidocel).
Discovery and Development of the First FDA Approved Drug for Diffuse Midline Gliomas — Joshua Allen, Ph.D. (Jazz Pharmaceuticals).
Development of Ligands for PET Imaging in Parkinson’s Disease — James Petersson, Ph.D. (University of Pennsylvania).
Mass Spectrometry in Academia & Industry — Shelly Gao (UPenn). Engaging Patient Communities — Chari Cohen (Hepatitis B Foundation). Invention of MK-7602 — Manuel de Lera Ruiz (Merck).
Clinical Development of Zanidatamab — Kevin Bellew (Jazz). Automation & AI in Drug Safety — Mina Ebeid; Nicole Schmid David (Genmab). RANO 2.0 Volumetric AI — Gene Kim (MERIT CRO).
Data Science for Pharma — Zhiyong Xie (Fosun). Lung Cancer Biology — Barzin Nabet (Genentech). Clinical Trials 2.0 — Feng Liu (Immunocore).
Women in Investment (Frazer): Lori Gough; Kathie Jordan; Michele Washko; Saima Farooq (Penn State Center for Medical Innovation). Innovation, Access & Partnership (Cent II, mod Jeff He): Hui Liu (Sandoz); Nehal Solanki Patel (Legend Biotech); Jack Wu (Takeda); Sam Ye (Daiichi Sankyo).
Lunch Seminars (12:00–1:00 PM): KACTUS — Sarah Rains (Haverford). TriApex — Guodong Zhang (Malvern). Apeloa — Lilith Elmore (Paoli).
AI & Agents in the Pharma Value Chain — Ron Kim, M.B.A. Advancing Drug Discovery and Development with AI and New Modalities — Siyuan Chen, M.B.A. (BMS).
Cancer Metabolism Across Scales — Yihui Shen (UPenn). HBV-miR-2/HBV-SITE Axis in HCC — Wenqiang Yu (Fudan). AI/ML in Oncology Discovery — Dowdy Jackson.
Novel Therapies for Cancer — Stacie Shepherd (Fore Bio). Bench to Bedside — Nageatte Ibrahim (Arc Nouvel). Rare Disease Clinical Dev — Haichen Yang (Amicus).
Overall Survival as Safety Endpoint — Zhiheng Xu (FDA). Dose Selection in Oncology — Fang Liu (Merck). AI/ML Modeling in Clinical Research — Helen Zhou (GSK).
Earning Growth & Promotion — Michelle Ottey (CIC). The Human Edge in an AI Era — Marcia Zaruba O’Connor. Science, Startups & Serendipity — Sharon Willis (Integral Molecular).
Panelists: Hao Chen (GSK); Chari Cohen (Blumberg Institute); Dowdy Jackson; Michael Kalos (Next Pillar); Baofa Yu (Immune Oncology Systems); Rui Liao (J&J Innovative Medicine).
PBPK in Big Pharma vs Biotech — Valeriu Damian (BioCryst). PBBM Approaches — Nikunjkumar Patel (Teva). Next-Gen PBPK — Gaohua Lu (BMS).
Agentic Clinical Development — Lucas Glass (IQVIA). AI QA/QC in Life Science — Tiaohao Wu (OpAIDA). Histology & Spatial Transcriptomics — Chao Chen (Stony Brook).
Dominique Demolle (Cognivia); Tifani McCann (Otsuka); Haichen Yang (Amicus).
Yufeng Li (Vivace); Haichen Nie (Teva); Helen Sun (Zambon); Patricia Tsao (CytoEX); Lu Wang (Genentech/Roche).
Equity Investing — Douglas Roman (Gamma International Bank). Life Science Supply Chain — Dan Leonard (UBS).
The 2026 Annual Conference is made possible by the generous support of our sponsors.
IOS Access the full program and brochure. Members save on registration for SAPA-GP events.
Full scheduleDownload brochureBecome a member & save